The sor gene of HIV-1 is required for efficient virus transmission in vitro.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Science

• Publication date

  1987-08-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.3497453PMID 3497453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome organization and transactivation of the human immunodeficiency virus type 2

  1987cited by this paper
• Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

  1986cited by this paper
• Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

  1986cited by this paper
• Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection

  1986cited by this paper
• How λ repressor and λ Cro distinguish between OR1 and OR3

  1986cited by this paper
• Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses.

  1986cited by this paper
• Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system.

  1986cited by this paper
• Sequence homology between cloned caprine arthritis encephalitis virus and visna virus, two neurotropic lentiviruses

  1986cited by this paper
• Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli.

  1986cited by this paper
• A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

  1986cited by this paper
• Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.

  1986cited by this paper
• The trans-activator gene of HTLV-III is essential for virus replication

  1986cited by this paper
• Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

  1985cited by this paper
• Human T-lymphotropic retroviruses

  1985cited by this paper
• A molecular clone of HTLV-III with biological activity

  1985cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

  1985cited by this paper
• Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.

  1985cited by this paper
• Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

  1985cited by this paper
• Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

  1985cited by this paper
• Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

  1985cited by this paper
• Nucleotide sequence of the AIDS virus, LAV.

  1985cited by this paper
• Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III.

  1985cited by this paper
• Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.

  1985cited by this paper
• Molecular cloning and characterization of the HTLV-III virus associated with AIDS

  1984cited by this paper
• Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.

  1984cited by this paper
• Immunoglobulin gene transcription is activated by downstream sequence elements.

  1983cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper
• The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

  1982cited by this paper
• Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line.

  1981cited by this paper
• SV40-transformed simian cells support the replication of early SV40 mutants.

  1981cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Size and location of the transforming region in human adenovirus type 5 DNA

  1974cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Host-Driven Ubiquitination Events in Vector-Transmitted RNA Virus Infections as Options for Broad-Spectrum Therapeutic Intervention Strategies

  2024cites this paper
• The Disassociation of A3G-Related HIV-1 cDNA G-to-A Hypermutation to Viral Infectivity

  2024cites this paper
• HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton

  2023cites this paper
• The coevolution between APOBEC3 and retrotransposons in primates

  2022cites this paper
• Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest

  2021cites this paper
• APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner

  2021cites this paper
• A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction

  2020cites this paper
• Structural perspectives on HIV‐1 Vif and APOBEC3 restriction factor interactions

  2020cites this paper
• Engineered RNA-Interacting CRISPR Guide RNAs for Genetic Sensing and Diagnostics

  2020cites this paper
• The Role of APOBECs in Viral Replication

  2020cites this paper
• Impact of natural HIV-1 Nef alleles and polymorphisms on SERINC3/5 downregulation

  2019cites this paper
• HIV restriction factor APOBEC3G binds in multiple steps and conformations to search and deaminate single-stranded DNA

  2019cites this paper
• Diversity in APOBEC3 and CCR5 host genes and HIV-1 in a South African population

  2018cites this paper
• Maedi-visna virus as a model for HIV

  2018cites this paper
• A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.

  2018cites this paper
• Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G

  2017cites this paper
• Diversidad del VIH-1. Transmisión dinámica y resistencias primarias en los nuevos diagnósticos de VIH-1 en la población de Málaga (HUVV) durante los años 2004-2015.

  2017influential citation
• Stabilité et fonctionnalité des glycoprotéines de l’enveloppe du VIH-1 recombinant CRF01_AE : rôle de l’histidine en position 375

  2017cites this paper
• APOBEC Enzymes as Targets for Virus and Cancer Therapy.

  2017cites this paper
• ANTIVIRAL SCREENING ASSAY INVOLVING THE DETECTION OF CEM15 EXPRESSION

  2017cites this paper
• CBFß and HIV Infection.

  2017cites this paper
• 7 Retroviral Host Cell Factors : TRIM 5 , APOBEC 3 G and Cyclophilins

  2017cites this paper
• Investigating the feasibility of incorporating Vpx into lentiviral gene therapy vectors: at a global and targeted scale

  2016cites this paper
• Effet de la stimulation du TLR2 et de la sécrétion d'acétate sur la susceptibilité à l'infection au VIH-1 des lymphocytes T CD4+ primaires

  2016cites this paper
• Restriction of HIV by Tim-family proteins and antagonism by NEF

  2016cites this paper
• Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif

  2015cites this paper
• Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.

  2015cites this paper
• Towards an in vivo HIV latency model based on humanized mice

  2015cites this paper
• Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition

  2014cites this paper
• HIV-1 Viral Infectivity Factor Recruitment of Cellular Protein Complexes to Counter Host Antiviral Response

  2014cites this paper
• Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

  2014cites this paper
• Identification and evaluation of inhibitors targeting the HIV-1 integrase-LEDGF/p75 interaction

  2014cites this paper
• Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins

  2014cites this paper
• Heat-Stable Molecule Derived from Streptococcus cristatus Induces APOBEC3 Expression and Inhibits HIV-1 Replication

  2014cites this paper
• The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation

  2014cites this paper
• Caractérisation de l'interaction entre Gag(NCp7) et la protéine cellulaire RPL7 : aspects moléculaire et fonctionnel

  2014cites this paper
• HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity

  2014cites this paper
• Vectors Cells by Feline Immunodeficiency Virus Transduction of Dividing and Nondividing Minimum Requirements for Efficient

  2013cites this paper
• Interactions between APOBEC3 and murine retroviruses: Mechanisms of restriction and drug resistance

  2013cites this paper
• HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors

  2013cites this paper
• HIV-1-Inhibiting Viral Protein Mutants Type 1 (HIV-1) Variant: Identification of Novel Nonproducer Human Immunodeficiency Virus Homologous Viral Interference Induced by a gag, vif, and nef Genes Contribute to the

  2013cites this paper
• Viral infectivity factor: a novel therapeutic strategy to block HIV-1 replication.

  2013cites this paper
• Exploring the binding mode of HIV-1 Vif inhibitors by blind docking, molecular dynamics and MM/GBSA

  2013cites this paper
• Étude du mécanisme moléculaire d'incorporation de la molécule de l'hôte ICAM-1 par le VIH-1

  2013cites this paper
• Optical tweezers reveal how proteins alter replication

  2013cites this paper
• Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid binding protein

  2013cites this paper
• virus type 2 vif gene. sequences in the human immunodeficiency Identification and mapping of inhibitory

  2013cites this paper
• [Multifunctional HIV accessory proteins are hub proteins antagonizing host antiviral factors].

  2013cites this paper
• Feline restriction factors to lentiviral replication

  2013cites this paper
• Vif in Virions Virus Type 1 Reveals a Virtual Absence of Highly Purified Human Immunodeficiency

  2013cites this paper
• Role of HIV-1 Vif in viral replication : translational regulation of APOBEC3G and RNA chaperone activity

  2013cites this paper
• The APOBEC3 family of retroelement restriction factors.

  2013cites this paper
• Étude du rôle de la protéine Vpr du VIH-1 dans la modulation de la réponse immunitaire

  2013cites this paper
• Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids

  2012cites this paper
• Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein

  2012cites this paper
• Infections lentivirales chez les petits ruminants domestiques : étude des relations hôte-pathogène et application en diagnostic

  2012cites this paper
• APOBEC3G Restricts HIV-1 to a Greater Extent than APOBEC3F and APOBEC3DE in Human Primary CD4+ T Cells and Macrophages

  2012cites this paper
• The role of the rhesus macaque (macaca mulatta) apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) in lentiviral replication and persistence

  2012cites this paper
• SIV replication in human cells

  2012influential citation
• Interaction of human immunodeficiency virus type 1 Vif with APOBEC3G is not dependent on serine/threonine phosphorylation status.

  2012cites this paper
• Sequence and structure requirements for specific recognition of HIV-1 TAR and DIS RNA by the HIV-1 Vif protein

  2012influential citation
• The evaluation of gold-based compounds as potential inhibitors of HIV-1 replication.

  2012cites this paper
• APOBEC 3 G Restricts HIV-1 to a Greater Extent than APOBEC 3 F and APOBEC 3 DE in Human Primary CD 4 T Cells and Macrophages

  2012cites this paper
• The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication.

  2012cites this paper
• Emerging Drug Targets for Antiretroviral Therapy

  2012cites this paper
• Synthesis and Structure–Activity Relationship Studies of HIV‐1 Virion Infectivity Factor (Vif) Inhibitors that Block Viral Replication

  2012cites this paper
• APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans

  2012cites this paper
• Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family

  2012influential citation
• On the solution conformation and dynamics of the HIV-1 viral infectivity factor.

  2011cites this paper
• Étude du mécanisme d’augmentation de la relâche virale par la protéine Vpu du VIH-1

  2011cites this paper
• The role of BST2/tetherin in feline retrovirus infection.

  2011cites this paper
• On HIV-1 restriction in human dendritic cells and peripheral blood mononuclear cells

  2011cites this paper
• Functional analysis of the two cytidine deaminase domains in APOBEC3G.

  2011cites this paper
• Identification of a Cullin5-ElonginB-ElonginC E3 Complex in Degradation of Feline Immunodeficiency Virus Vif-Mediated Feline APOBEC3 Proteins

  2011cites this paper
• In vitro selection and characterisation of human anti-HIV-1 antibody fragments

  2011cites this paper
• Retroviral Host Cell Factors: TRIM5, APOBEC3G and Cyclophilins

  2011cites this paper
• HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

  2010cites this paper
• Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

  2010cites this paper
• Vpu Mediated Enhancement of Human Immunodeficiency Virus Pathogenesis: The Role of Conserved and Unique Domains in Protein Function

  2010cites this paper
• Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G*

  2010cites this paper
• Identification of a Critical T(Q/D/E)x5ADx2(I/L) Motif from Primate Lentivirus Vif Proteins That Regulate APOBEC3G and APOBEC3F Neutralizing Activity

  2010cites this paper
• The Associations of hA3G and hA3B mRNA Levels With HIV Disease Progression Among HIV-Infected Individuals of China

  2010cites this paper
• Cell entry and exit of porcine endogenous retrovirus A: receptors and release inhibitor

  2010cites this paper
• Manipulation of the ubiquitin-proteasome system by HIV-1 : role of the accessory protein Vpr

  2010cites this paper
• Identification of a Critical T(Q/D/E)x 5 ADx 2 (I/L) Motif from Primate Lentivirus Vif Proteins That Regulate APOBEC3G and APOBEC3F Neutralizing Activity (cid:1)

  2010cites this paper
• Host Factors that Restrict Retrovirus Replication

  2009cites this paper
• Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

  2009cites this paper
• Identification of a Novel WxSLVK Motif in the N Terminus of Human Immunodeficiency Virus and Simian Immunodeficiency Virus Vif That Is Critical for APOBEC3G and APOBEC3F Neutralization

  2009cites this paper
• APOBEC proteins and intrinsic resistance to HIV-1 infection

  2009cites this paper
• MULTIPLE WAYS OF TARGETING APOBEC3/VIF INTERACTIONS FOR ANTI-HIV-1 DRUG DEVELOPMENT

  2009cites this paper
• Cloning and characterization of MRI, a modulator of retroviral infection

  2009cites this paper
• Molecular structure and biochemical properties of the HCCH-Zn2+ site in HIV-1 Vif.

  2009cites this paper
• Identification of the Function of the Vpx Protein of Primate Lentiviruses: A Dissertation

  2009cites this paper
• Conformational analysis of a peptide approximating the HCCH motif in HIV‐1 Vif

  2009cites this paper
• APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages.

  2008cites this paper
• Host restriction factors blocking retroviral replication.

  2008influential citation
• Single molecule force spectroscopy studies of DNA binding and chaperone proteins

  2008cites this paper
• Studies of entry, reverse transcription, and regulation of splicing in retroviruses

  2008cites this paper
• Species barrier of HIV‐1 and its jumping by virus engineering

  2008cites this paper
• Recombinant intracellular antibodies for molecular gene therapy of HIV-1 infection

  2008cites this paper